Abstract
Novel 3-thio-1,2,4-triazoles have been obtained via a solution-phase parallel synthesis strategy, affording potent non-peptidic human somatostatin receptor subtypes 2 and 5 agonists.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have